Preoperative contrast-enhanced CT prediction of distinct vascular patterns in solitary early-stage hepatocellular carcinoma and its prognostic value.

IF 4.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Wanli Zhang, Wen Lv, Yi Long, Jiaxin Lin, Jiamin Li, Chuanxian Zhang, Yandong Zhao, Jie Zhan, Shengsheng Lai, Mingyong Gao, Xinqing Jiang, Ruimeng Yang
{"title":"Preoperative contrast-enhanced CT prediction of distinct vascular patterns in solitary early-stage hepatocellular carcinoma and its prognostic value.","authors":"Wanli Zhang, Wen Lv, Yi Long, Jiaxin Lin, Jiamin Li, Chuanxian Zhang, Yandong Zhao, Jie Zhan, Shengsheng Lai, Mingyong Gao, Xinqing Jiang, Ruimeng Yang","doi":"10.1186/s13244-026-02224-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the value of qualitative and quantitative contrast-enhanced CT (CECT) features for noninvasive identification of two distinct vascular patterns, vessels that encapsulate tumor clusters (VETC) and/or microvascular invasion (MVI), in solitary early-stage (BCLC 0-A) hepatocellular carcinoma (HCC) and assess their prognostic implications.</p><p><strong>Materials and methods: </strong>We retrospectively included 347 patients with solitary early-stage HCC who underwent preoperative CECT and subsequent resection at two centers. Patients were divided into V/M+ (MVI and/or VETC positive, n = 174) and VM- (both MVI and VETC negative, n = 173) groups based on histopathology. Four predictive models (clinical, CT quantitative, CT qualitative, and combined) integrating clinical and CECT features were developed and validated for identifying V/M+ status. The optimal model was further applied to predict 2-year recurrence-free survival (RFS). Sensitivity analysis was performed using propensity score matching (PSM). Models' performance was evaluated and compared using AUC analyses and DeLong tests.</p><p><strong>Results: </strong>The combined model [serum AFP ≥ 200 ng/mL, non-smooth tumor margin, internal arteries, and lower tumor-to-liver density ratio in the portal venous phase (P-TLR)] achieved optimal predictive performance for V/M + HCC, with training AUC of 0.784 and 0.782 pre- and post-PSM, and external validating AUC of 0.794. A derived V/M+ score stratified patients, with higher scores associated with significantly shorter 2-year RFS. V/M+ score ≥ 34 and tumor size ≥ 60 mm were significant predictors of HCC recurrence (p < 0.05).</p><p><strong>Conclusion: </strong>The combined model integrating clinical and CECT-based features, enables non-invasive assessment of V/M status in early-stage solitary HCC and effectively stratifies patients according to recurrence risk.</p><p><strong>Critical relevance statement: </strong>Specific CT-based qualitative and quantitative features are associated with a distinct vascular pattern of BCLC stage 0-A HCC. The developed combined model and derived V/M+ score offer a reliable tool for clinicians to predict V/M + HCC and patients' 2-year RFS.</p><p><strong>Key points: </strong>Specific CECT-based qualitative and quantitative features are associated with V/M + HCC at the BCLC stage 0-A. The developed combined model offers a reliable tool for clinicians to identify V/M + HCC. The derived V/M+ score helps stratify HCC patients into high- and low-risk groups for 2-year RFS, facilitating personalized management of HCC.</p>","PeriodicalId":13639,"journal":{"name":"Insights into Imaging","volume":"17 1","pages":"49"},"PeriodicalIF":4.5000,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909690/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Insights into Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13244-026-02224-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To investigate the value of qualitative and quantitative contrast-enhanced CT (CECT) features for noninvasive identification of two distinct vascular patterns, vessels that encapsulate tumor clusters (VETC) and/or microvascular invasion (MVI), in solitary early-stage (BCLC 0-A) hepatocellular carcinoma (HCC) and assess their prognostic implications.

Materials and methods: We retrospectively included 347 patients with solitary early-stage HCC who underwent preoperative CECT and subsequent resection at two centers. Patients were divided into V/M+ (MVI and/or VETC positive, n = 174) and VM- (both MVI and VETC negative, n = 173) groups based on histopathology. Four predictive models (clinical, CT quantitative, CT qualitative, and combined) integrating clinical and CECT features were developed and validated for identifying V/M+ status. The optimal model was further applied to predict 2-year recurrence-free survival (RFS). Sensitivity analysis was performed using propensity score matching (PSM). Models' performance was evaluated and compared using AUC analyses and DeLong tests.

Results: The combined model [serum AFP ≥ 200 ng/mL, non-smooth tumor margin, internal arteries, and lower tumor-to-liver density ratio in the portal venous phase (P-TLR)] achieved optimal predictive performance for V/M + HCC, with training AUC of 0.784 and 0.782 pre- and post-PSM, and external validating AUC of 0.794. A derived V/M+ score stratified patients, with higher scores associated with significantly shorter 2-year RFS. V/M+ score ≥ 34 and tumor size ≥ 60 mm were significant predictors of HCC recurrence (p < 0.05).

Conclusion: The combined model integrating clinical and CECT-based features, enables non-invasive assessment of V/M status in early-stage solitary HCC and effectively stratifies patients according to recurrence risk.

Critical relevance statement: Specific CT-based qualitative and quantitative features are associated with a distinct vascular pattern of BCLC stage 0-A HCC. The developed combined model and derived V/M+ score offer a reliable tool for clinicians to predict V/M + HCC and patients' 2-year RFS.

Key points: Specific CECT-based qualitative and quantitative features are associated with V/M + HCC at the BCLC stage 0-A. The developed combined model offers a reliable tool for clinicians to identify V/M + HCC. The derived V/M+ score helps stratify HCC patients into high- and low-risk groups for 2-year RFS, facilitating personalized management of HCC.

孤立性早期肝细胞癌术前CT增强预测不同血管形态及其预后价值。
目的:探讨定性和定量对比增强CT (CECT)特征在单发早期(BCLC - 0-A)肝细胞癌(HCC)中两种不同血管模式的无创识别价值,即包裹肿瘤簇的血管(VETC)和/或微血管侵犯(MVI),并评估其预后意义。材料和方法:我们回顾性地纳入了347例孤立性早期HCC患者,他们在两个中心接受了术前CECT和随后的切除术。根据组织病理学将患者分为V/M+组(MVI和/或VETC阳性,n = 174)和VM-组(MVI和/或VETC阴性,n = 173)。四种预测模型(临床、CT定量、CT定性和联合)整合临床和CECT特征,用于识别V/M+状态。进一步应用最优模型预测2年无复发生存期(RFS)。采用倾向评分匹配(PSM)进行敏感性分析。使用AUC分析和DeLong测试对模型的性能进行了评估和比较。结果:联合模型[血清AFP≥200 ng/mL,肿瘤边缘不光滑,内动脉,门静脉期肿瘤与肝密度比较低]对V/M + HCC的预测效果最佳,psm前后的训练AUC分别为0.784和0.782,外部验证AUC为0.794。衍生的V/M+评分对患者进行分层,评分越高,2年RFS明显越短。V/M+评分≥34,肿瘤大小≥60 mm是HCC复发的重要预测因子(p)结论:结合临床特征和基于cect的联合模型能够无创地评估早期孤立性HCC的V/M状态,并能有效地根据复发风险对患者进行分层。关键相关性声明:特定的基于ct的定性和定量特征与BCLC 0-A期HCC的独特血管模式相关。开发的联合模型和导出的V/M+评分为临床医生预测V/M+ HCC和患者2年RFS提供了可靠的工具。重点:特定的基于cect的定性和定量特征与BCLC 0-A期V/M + HCC相关。开发的联合模型为临床医生识别V/M + HCC提供了可靠的工具。衍生的V/M+评分有助于将HCC患者分为高危组和低危组,进行2年RFS,便于HCC的个性化管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Insights into Imaging
Insights into Imaging Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
7.30
自引率
4.30%
发文量
182
审稿时长
13 weeks
期刊介绍: Insights into Imaging (I³) is a peer-reviewed open access journal published under the brand SpringerOpen. All content published in the journal is freely available online to anyone, anywhere! I³ continuously updates scientific knowledge and progress in best-practice standards in radiology through the publication of original articles and state-of-the-art reviews and opinions, along with recommendations and statements from the leading radiological societies in Europe. Founded by the European Society of Radiology (ESR), I³ creates a platform for educational material, guidelines and recommendations, and a forum for topics of controversy. A balanced combination of review articles, original papers, short communications from European radiological congresses and information on society matters makes I³ an indispensable source for current information in this field. I³ is owned by the ESR, however authors retain copyright to their article according to the Creative Commons Attribution License (see Copyright and License Agreement). All articles can be read, redistributed and reused for free, as long as the author of the original work is cited properly. The open access fees (article-processing charges) for this journal are kindly sponsored by ESR for all Members. The journal went open access in 2012, which means that all articles published since then are freely available online.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书